Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$17.49 - $26.72 $468,609 - $715,908
-26,793 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$17.47 - $27.49 $311,944 - $490,861
-17,856 Reduced 39.99%
26,793 $667,000
Q2 2021

Aug 16, 2021

BUY
$23.73 - $27.98 $1.06 Million - $1.25 Million
44,649 New
44,649 $1.06 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $241M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Connacht Asset Management LP Portfolio

Follow Connacht Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connacht Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Connacht Asset Management LP with notifications on news.